Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment

EMA - Emergency Medicine Australasia

Volumn 24, Issue 4, 2012, Pages 383-392

  Garrett, Tim ^a,c   Harbort, Yvonne ^b   Trebble, Mary ^b   Docherty, Toni ^a  

^a Central Coast Local Health District ^*  (Australia)

^b Central Coast Local Health District   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cellulitis; Cephazolin; Probenecid

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; FLUCLOXACILLIN; PENICILLIN G; PROBENECID; TIMENTIN; VANCOMYCIN;

ADULT; AGED; ALGORITHM; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CELLULITIS; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE COURSE; DOSAGE SCHEDULE COMPARISON; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL REFLUX; HEADACHE; HOME CARE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NAUSEA; OBSERVATIONAL STUDY; ONLINE SYSTEM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; THRUSH; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-BACTERIAL AGENTS; CEFAZOLIN; CELLULITIS; DISEASE PROGRESSION; FEMALE; HOME CARE SERVICES; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; NEW SOUTH WALES; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864751269     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2012.01553.x     Document Type: Article

References (30)

1. Australian Institute of Health and Welfare. Canberra: Australian hospital statistics 2009-10. Health services series no. 40. Cat. no. HSE 107. [Cited 30 Jul 2011.] Available from URL:.
2. Hook EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turch M. Microbiologic evaluation of cutaneous cellulitis in Adults. Arch. Intern. Med. 1986; 146: 295-7.
3. Moran GJ, Krishnadasan A, Gorwitz RJ etal. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 2006; 355: 666-74.
4. Spellberg B, Talbot GH, Boucher HW etal. Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin. Infect. Dis. 2009; 49: 383-91.
5. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique. Arch. Dermatol. 1989; 125: 779-82.
6. Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin. Infect. Dis. 1996; 23: 1091-8.
7. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Version 14. ISBN: 9780980476477. Melbourne: Therapeutic Guidelines Limited, 2010.
8. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin. Infect. Dis. 2007; 44: 777-84.
9. Stevens DL, Bisno AL, Chambers HF etal. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 2005; 41: 1373-406.
10. Rajendran PM, Young D, Maurer T etal. Randomized, double-blind, placebocontrolled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob. Agents Chemother. 2007; 51: 4044-8.
11. Fridkin SK, Hageman JC, Morrison M etal. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 2005; 352: 1436-44.
12. Paydar KZ, Hansen SL, Charlebois ED, Harris HW, Young DM. Inappropriate antibiotic use in soft tissue infections. Arch. Surg. 2006; 141: 850-56.
13. Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care. Med. J. Aust. 1995; 162: 249-53.
14. Leder K, Turnidge JD, Grayson ML. Home-based treatment of cellulitis with twice-daily cefazolin. Med. J. Aust. 1998; 169: 519-22.
15. Montalto M, Dunt D. Home and hospital intravenous therapy for two acute infections: an early study. Aust. N. Z. J. Med. 1997; 27: 19-23.
16. Tice AD. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur. J. Clin. Microbiol. Infect. Dis. 1995; 14: 655-61.
17. Dall L, Peddicord T, Peterson S, Simmons T, Dall T. Hospitalist treatment of CAP and cellulitis using objective criteria to select patients. Infect. Med. 2003; 20: 379-90.
18. Montalto M. Patients' and carers' satisfaction with hospital-in-the-home care. Int. J. Qual. Health Care 1996; 8: 243-51.
19. Dubois A, Santis-Eggimann B. Evaluation of patients' satisfaction with hospital-at-home care. Eval. Health Prof. 2001; 24: 84-98.
20. Leff B, Burton L, Mader SL etal. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann. Intern. Med. 2005; 143: 798-808.
21. Brown G, Zemcov SJV, Clarke AM. The effect of probenecid in cefazolin serum concentrations. J. Antimicrob. Chemother. 1993; 31: 1009-11.
22. Grayson ML, McDonald M, Gibson K etal. Once-daily intravenous cephazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin. Infect. Dis. 2002; 34: 1440-48.
23. Australian Bureau of Statistics. Canberra: Gosford-Wyong (Statistical Region). [Released Oct 2007, updated Feb 2008, cited 15 October 2011.] Available from URL:.
24. Bureau of Health Information. Sydney: Hospital Quarterly: Performance of NSW Public Hospitals. [Cited 15 October 2011.] Available from URL:.
25. Goto S. The in-vitro and in-vivo antibacterial activity of cefuroxime. Proc. R. Soc. Med. 1977; 70 (9): 56-62.
26. Brown G, Chamberlain R, Goulding J, Clarke A. Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections. J. Emerg. Med. 1996; 14: 547-51.
27. Rostoker G, Andrivet P, Pham I, Criuncelli M, Adnot S. A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate. J. Nephrol. 2007; 20: 576-85.
28. Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch. Intern. Med. 2001; 161: 61-5.
29. Corwin P, Toop L, McGeoch G etal. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ 2005; 330: 129-34.
30. Donald M, Marlow N, Swinburn E, Wu M. Emergency department management of home intravenous antibiotic therapy for cellulitis. Emerg. Med. J. 2005; 22: 715-17.